1. Home
  2. HALO

as 10-07-2025 3:29pm EST

$
-
-
.
-
-
-
$
-
.
-
-
-
-
.
-
-
%

Stocks

Health Care

Biotechnology: Biological Products (No Diagnostic Substances)

Nasdaq

Halozyme Therapeutics Inc is a biotechnology company focused on developing and commercializing novel oncology therapies. The company seeks to create therapies focused on human enzymes that alter tumors. Halozyme focuses on developing its proprietary products in therapeutic areas with a focus on oncology, and licensing its technology to biopharmaceutical companies to collaboratively develop products. The company's operations are based in the United States, with minimal long-lived assets located internationally.

Founded: 1998 Country:
United States
United States
Employees: N/A City: SAN DIEGO
Market Cap: 9.0B IPO Year: N/A
Target Price: $73.40 AVG Volume (30 days): 2.2M
Analyst Decision: Buy Number of Analysts: 10
Dividend Yield:
N/A
Dividend Payout Frequency: N/A
EPS: 4.37 EPS Growth: 68.93
52 Week Low/High: $42.01 - $79.50 Next Earning Date: 10-30-2025
Revenue: $1,178,672,000 Revenue Growth: 34.97%
Revenue Growth (this year): 32.57% Revenue Growth (next year): 23.25%

Stock Insider Trading Activity of Halozyme Therapeutics Inc. (HALO)

Name Ticker Relationship Date Transaction AVG Cost Per Share Shares Total Value Securities Owned After Transaction(s) SEC Form 4
Torley Helen HALO PRESIDENT AND CEO Oct 3 '25 Sell $70.14 20,000 $1,380,638.14 733,719
Torley Helen HALO PRESIDENT AND CEO Oct 2 '25 Sell $72.35 20,000 $1,424,082.70 733,719
Torley Helen HALO PRESIDENT AND CEO Oct 1 '25 Sell $75.40 20,000 $1,507,024.28 733,719
Connaughton Bernadette HALO Director Oct 1 '25 Sell $75.40 2,000 $150,481.00 44,952
LaBrosse Nicole HALO SVP, CHIEF FINANCIAL OFFICER Sep 22 '25 Sell $78.25 2,227 $173,584.49 22,079
LaBrosse Nicole HALO SVP, CHIEF FINANCIAL OFFICER Sep 10 '25 Sell $75.61 20,000 $1,514,267.12 22,079
Torley Helen HALO PRESIDENT AND CEO Sep 4 '25 Sell $74.36 20,000 $1,480,772.20 733,719
Torley Helen HALO PRESIDENT AND CEO Sep 3 '25 Sell $74.43 20,000 $1,488,726.00 733,719
Torley Helen HALO PRESIDENT AND CEO Sep 2 '25 Sell $73.44 20,000 $1,475,128.09 733,719
Connaughton Bernadette HALO Director Sep 2 '25 Sell $73.15 4,000 $294,736.24 44,952

Share on Social Networks: